by Keishi Foecke | Sep 30, 2025 | PULSE Partner
In this guest blog, Kristin Jones, CEO of PULSE Partner Indiana Life Sciences Association, discusses how pro-competitive mergers and acquisitions (M&A) have played a crucial role in supporting collaborations between universities, academic researchers and life...
by Keishi Foecke | Sep 4, 2025 | Blog Post
Following a recent Trump Administration executive order, the Federal Trade Commission (FTC) and Department of Justice (DOJ) both released statements signaling a shift to a more balanced approach to mergers and acquisitions (M&A)...
by Keishi Foecke | Aug 28, 2025 | Blog Post
Investment in early-stage life sciences companies is critical to sustain America’s global leadership in discovering and developing new medical breakthroughs for patients, according to a recent General Catalyst blog, “The Future of Life Sciences Investment.”...
by Keishi Foecke | Aug 6, 2025 | Innovations Advanced by M&A
This blog is another installment in a series, Innovations Advanced by M&A, that underscores the unique role of mergers and acquisitions in promoting a competitive and innovative life sciences ecosystem for patients. You can find previous blogs in this...
by Keishi Foecke | Jul 30, 2025 | Blog Post
The Federal Trade Commission (FTC) and Department of Justice (DOJ)’s approach toward mergers and acquisitions (M&A) is obstructing a critical exit point for innovative early-stage companies, according to Vanderbilt University Law School professor Brian Broughman...
by Keishi Foecke | Jul 23, 2025 | PULSE Partner
In a recent op-ed for Deseret News, Kelvyn Cullimore, CEO of PULSE Partner BioUtah, emphasizes the importance of federal policies that support pro-competitive life sciences mergers and acquisitions (M&A), in order to sustain innovation and growth in the life...
